Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
VNDA > SEC Filings for VNDA > Form 8-K on 18-Dec-2012All Recent SEC Filings

Show all filings for VANDA PHARMACEUTICALS INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for VANDA PHARMACEUTICALS INC.

18-Dec-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events

On December 18, 2012, Vanda Pharmaceuticals Inc. issued a press release announcing the results from its Safety and Efficacy of Tasimelteon (SET) Phase III study. A copy of the press release is filed as Exhibit 99.1 hereto and incorporated by reference herein.



Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit
No. Description

99.1 Press Release of Vanda Pharmaceuticals Inc. dated December 18, 2012.

  Add VNDA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for VNDA - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.